POMDOCTOR's IPO

Q: When does the lock-up end?

POMDOCTOR's IPO lock-up ends Apr 9, 2026. Its final prospectus says: “.”

Listed Oct 8, 2025 at $4 on Nasdaq as POM.

Offer price

Market cap

$79M

ADSs

5,000,004

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

See all 16 new listings ranked

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its final prospectus (424B4) on SEC EDGAR, filed Oct 9, 2025.

What does POMDOCTOR do?

“We are a leading online medical services platform for chronic diseases in China, ranking sixth on China's Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan.”

From its final prospectus (424B4), filed Oct 9, 2025

POMDOCTOR's facts, each with its source
Fact	POMDOCTOR
Website	7lk.comFrom its final prospectus (424B4) of Oct 9, 2025

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

POMDOCTOR's facts, each with its source
Fact	POMDOCTOR
Shares offered	5,000,004 ADSsFrom the final prospectus (424B4) filed Oct 9, 2025
Offer price	$4 per ADSFrom the final prospectus (424B4) filed Oct 9, 2025
Exchange	Nasdaq Global Market, as POMFrom the final prospectus (424B4) filed Oct 9, 2025
Shares outstanding after	19,740,760From the final prospectus (424B4) filed Oct 9, 2025
Market cap at the offer price	$79 millionBreakaway's arithmetic from the prospectus's share count

What the filing says about its money

POMDOCTOR's facts, each with its source
Fact	POMDOCTOR
Net loss	$143 million, year to December 31, 2024From its final prospectus (424B4) of Oct 9, 2025, its summary financial data
Last preferred stock	Series A preferredFrom its final prospectus (424B4) of Oct 9, 2025

What risks does POMDOCTOR name first?

“Maintaining customers' trust in our ecosystem is critical to our success, and any failure to do so could severely damage our reputation and brand.”
“We are in the early stage of development with a limited operating history in an emerging and dynamic "Internet + healthcare" industry, and our historical results of operations and financial performance are not indicative of future performance.”
“If we are unable to compete effectively, our business, financial condition and results of operations may be materially and adversely affected.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of POMDOCTOR's IPO

POMDOCTOR's IPO dates, each with its source
What	Day	Source
Registration filedForm F-1, SEC EDGAR	Mar 13, 2025	Form F-1, SEC EDGAR
Exchange registration filedexchange registration (Form 8-A), SEC EDGAR	Jul 15, 2025	exchange registration (Form 8-A), SEC EDGAR
Declared effective by the SECSEC notice of effectiveness, SEC EDGAR	Sep 30, 2025	SEC notice of effectiveness, SEC EDGAR
First tradeMassive's IPO calendar	Oct 8, 2025	Massive's IPO calendar
Pricedfinal prospectus (424B4), SEC EDGAR	Oct 9, 2025	final prospectus (424B4), SEC EDGAR
Lock-up endsfinal prospectus, SEC EDGAR: “”	Apr 9, 2026	final prospectus, SEC EDGAR: “”

The other IPOs expected

The other IPOs expected or in registration
Company	Price	Market cap	Expected
OPAYNYSE: OPAY · No day yet	$19 to $21	Not yet	No day yetexchange registration Oct 26
Georgia BankingNasdaq: GBC · No day yet	Direct	Not yet	No day yetexchange registration Oct 21
Aspen NeuroscienceNasdaq: ASPE · No day yet	$15 to $17About $465M	$465Mat the midpoint	No day yetterms set Oct 26
Bambusa TherapeuticsNasdaq: BBTX · No day yet	$15 to $17About $796M	$796Mat the midpoint	No day yetterms set Oct 26
BitariNasdaq: BIAI · No day yet	$7About $302M	$302Mat the midpoint	No day yetterms set Oct 26
LIS TechnologiesNasdaq · No day yet	$5 to $7	Not yet	No day yetterms set Oct 26

POMDOCTOR IPO questions

When is POMDOCTOR's IPO?

Listed Oct 8, 2025 at $4 on Nasdaq as POM.

What is POMDOCTOR's IPO price?

POMDOCTOR's IPO priced at $4 a share, per its final prospectus of Oct 9, 2025.

How many shares is POMDOCTOR selling?

5,000,004 ADSs, per its final prospectus (424B4).

When does the lock-up end?

POMDOCTOR's IPO lock-⁠up ends Apr 9, 2026. Its final prospectus says: “.”

Does Breakaway rate POMDOCTOR?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where POMDOCTOR's price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Every new listing, ranked live, free. No account.

See all 16 new listings ranked

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed, and October 2025's listings.